Ningfei An, Ph.D.
Ningfei obtained her Bachelor of Science (BSc) degree from the Department of Pharmaceutical Analysis at Shenyang Pharmaceutical University in China and continued in the same institution to fulfill the requirements for her Master’s degree (MSc) in Pharmacology in 2002. In August of 2002, Dr. An was accepted into the doctoral program in the Department of Pharmacology, Louisiana State University Health Sciences Center, New Orleans, where she worked on understanding the regulatory roles of a newly discovered protein, Frmpd1. At the Medical University of South Carolina, Ningfei’s post-doctoral work focused on the role of Pim kinase in hematopoietic stem cell function and T-ALL. She has published over 20 manuscripts in leading stem cell and hematology journals. Ningfei has developed a genetically accurate mouse model of high-risk myeloid neoplasia. She is now using this as a preclinical in vivo model to identify new therapeutic targets.